State Street’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $406K | Buy |
239,987
+27,800
| +13% | +$57.2K | ﹤0.01% | 3711 |
|
|
2025
Q4 | $420K | Sell |
212,187
-850
| -0.4% | -$2.72K | ﹤0.01% | 3723 |
|
|
2025
Q3 | $620K | Sell |
213,037
-4,290
| -2% | -$9.87K | ﹤0.01% | 3612 |
|
|
2025
Q2 | $393K | Sell |
217,327
-656,619
| -75% | -$1.17M | ﹤0.01% | 3668 |
|
|
2025
Q1 | $1.31M | Sell |
873,946
-122,716
| -12% | -$310K | ﹤0.01% | 3372 |
|
|
2024
Q4 | $2.35M | Sell |
996,662
-166,087
| -14% | -$2.92M | ﹤0.01% | 3265 |
|
|
2024
Q3 | $34.2M | Sell |
1,162,749
-14,228
| -1% | -$328K | ﹤0.01% | 1891 |
|
|
2024
Q2 | $14.5M | Buy |
1,176,977
+83,499
| +8% | +$1.76M | ﹤0.01% | 2331 |
|
|
2024
Q1 | $22.2M | Buy |
1,093,478
+23,829
| +2% | +$549K | ﹤0.01% | 2148 |
|
|
2023
Q4 | $24.1M | Buy |
1,069,649
+44,059
| +4% | +$931K | ﹤0.01% | 2115 |
|
|
2023
Q3 | $17.1M | Buy |
1,025,590
+73,505
| +8% | +$1.46M | ﹤0.01% | 2259 |
|
|
2023
Q2 | $23.3M | Sell |
952,085
-106,864
| -10% | -$2.57M | ﹤0.01% | 2155 |
|
|
2023
Q1 | $25.5M | Buy |
1,058,949
+64,903
| +7% | +$1.8M | ﹤0.01% | 2058 |
|
|
2022
Q4 | $29.4M | Sell |
994,046
-3,203
| -0.3% | -$115K | ﹤0.01% | 1975 |
|
|
2022
Q3 | $41.7M | Sell |
997,249
-2,819
| -0.3% | -$76.1K | ﹤0.01% | 1721 |
|
|
2022
Q2 | $28.1M | Sell |
1,000,068
-53,888
| -5% | -$1.36M | ﹤0.01% | 2002 |
|
|
2022
Q1 | $39.1M | Buy |
1,053,956
+77,830
| +8% | +$3.3M | ﹤0.01% | 1913 |
|
|
2021
Q4 | $42.7M | Buy |
976,126
+37,040
| +4% | +$1.94M | ﹤0.01% | 1925 |
|
|
2021
Q3 | $58.3M | Buy |
939,086
+69,208
| +8% | +$5.78M | ﹤0.01% | 1700 |
|
|
2021
Q2 | $74.3M | Buy |
869,878
+183,568
| +27% | +$9.83M | ﹤0.01% | 1544 |
|
|
2021
Q1 | $30.9M | Buy |
686,310
+237,758
| +53% | +$9.35M | ﹤0.01% | 2084 |
|
|
2020
Q4 | $3.06M | Buy |
448,552
+96,050
| +27% | +$858K | ﹤0.01% | 3185 |
|
|
2020
Q3 | $4.06M | Buy |
352,502
+117,796
| +50% | +$531K | ﹤0.01% | 2881 |
|
|
2020
Q2 | $723K | Buy |
+234,706
| New | +$1.06M | ﹤0.01% | 3486 |
|
|
2017
Q2 | – | Sell |
-3,621
| Closed | -$22K | – | 3723 |
|
|
2017
Q1 | $22K | Hold |
3,621
| – | – | ﹤0.01% | 3612 |
|
|
2016
Q4 | $15K | Sell |
3,621
-26
| -0.7% | -$121 | ﹤0.01% | 3623 |
|
|
2016
Q3 | $23K | Sell |
3,647
-1,817
| -33% | -$30.1K | ﹤0.01% | 3529 |
|
|
2016
Q2 | $84K | Sell |
5,464
-371
| -6% | -$5.88K | ﹤0.01% | 3556 |
|
|
2016
Q1 | $91K | Hold |
5,835
| – | – | ﹤0.01% | 3564 |
|
|
2015
Q4 | $73K | Sell |
5,835
-155
| -3% | -$2.05K | ﹤0.01% | 3565 |
|
|
2015
Q3 | $77K | Sell |
5,990
-1,571
| -21% | -$19.8K | ﹤0.01% | 3555 |
|
|
2015
Q2 | $92K | Sell |
7,561
-51,600
| -87% | -$707K | ﹤0.01% | 3545 |
|
|
2015
Q1 | $783K | Buy |
59,161
+6,132
| +12% | +$82.7K | ﹤0.01% | 3280 |
|
|
2014
Q4 | $755K | Buy |
53,029
+635
| +1% | +$11K | ﹤0.01% | 3319 |
|
|
2014
Q3 | $1.44M | Buy |
52,394
+103
| +0.2% | +$3.13K | ﹤0.01% | 3150 |
|
|
2014
Q2 | $2.11M | Buy |
52,291
+48,316
| +1,215% | +$1.79M | ﹤0.01% | 3046 |
|
|
2014
Q1 | $153K | Hold |
3,975
| – | – | ﹤0.01% | 3480 |
|
|
2013
Q4 | $135K | Sell |
3,975
-1,415
| -26% | -$37.6K | ﹤0.01% | 3469 |
|
|
2013
Q3 | $103K | Sell |
5,390
-557
| -9% | -$9.74K | ﹤0.01% | 3460 |
|
|
2013
Q2 | $92K | Buy |
+5,947
| New | +$126K | ﹤0.01% | 3387 |
|
Other funds holding FLNA
VCM
GC
State Street's FLNA Position: Q1 2026 in Review
State Street increased its Filana Therapeutics (FLNA) stake by 13% in Q1 2026, buying an estimated $57.2K and bringing the position to 239,987 shares worth $406K. The position accounts for ﹤0.01% of the portfolio, ranked #3711.
State Street first reported a position in FLNA in Q2 2013 and has held it in 40 quarters since. The position peaked at $74.3M in Q2 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.
- State Street held 239,987 shares of Filana Therapeutics worth $406K as of Q1 2026.
- State Street bought 27,800 Filana Therapeutics shares in Q1 2026, an estimated $57.2K.
- Filana Therapeutics made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3711 holding.
- State Street first reported a position in Filana Therapeutics in Q2 2013 and has held it in 40 quarters since.
- State Street's Filana Therapeutics position peaked at $74.3M in Q2 2021.
- 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.